Our capabilities across data modalities
Supporting the analysis of a wide range of digital health data modalities to generate novel insights
Our capabilities across data modalities
Supporting the analysis of a wide range of digital health data modalities to generate novel insights
SOPHiA DDM™ for Multimodal
Combining high-quality data for each individual to generate multimodal insights, SOPHiA GENETICS harnesses the power of advanced AI and machine learning models.
Today, the SOPHiA DDM™ platform enables the analysis of clinical, biological, genomics and radiomics data. In the future, we intend to support additional data modalities such as digital pathology, proteomics and metabolomics.
The SOPHiA DDM™ platform's predictive modeling capabilities include disease screening, early detection, diagnosis and subtype discrimination, disease evolution, response to therapy, therapy selection and monitoring.
Future modalities
Proteomics
Digital pathology
Spatial genomics
Metabolomics
Transcriptomics
Epigenomics
Clinical data from EHR
What’s next?
A limited but rapidly increasing body of literature suggests that, thanks to novel computing capacities, multimodality holds the potential to increase precision in diagnosis, prognosis and treatment decision.
It is likely that exciting innovations will come from multimodal approaches that transform progress for patients around the world with:
• Discovery of novel biomarkers
• Development of new therapies
• Improved clinical trial matching
• The right treatment for patients in routine clinical care
Why SOPHiA GENETICS
Genomic Profiles
840,000
More than 840,000 genomics profiles analyzedSafety
Safe & secure
Cybersecurity and data protection are core pillars of our company.
Safe & secure
Cybersecurity and data protection are core pillars of our company.Technology
Technology-agnostic
An analytic platform for key solutions across data modalities
Want to know more?
Get in touch with us.
Our client services team is on hand to help.